A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

The facts on small-cell lung cancer, or SCLC, and non-small-cell lung cancer, or NSCLC, like symptoms, prognosis, treatment, and recovery.

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Researchers have looked at the rate of lung cancer diagnosis by age. We'll discuss the science behind the statistics.

There are two main types of lung cancer: non-small cell and small-cell. Learn about how these lung cancers are caused, and more.

Cancer is definitely a fatal disease, but if it is identified in the early stages and its treatment is started, then the chances of the patient's survival are very high. Cancer is a life-threatening ...

In this article, we investigated the survival rates for small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).

Medically reviewed by Benjamin Leach, MD Lung cancer survival rates can be as high as 98% for certain cancers diagnosed in an early stage, and as low as 4% for those diagnosed with more aggressive ...

It can be overwhelming to be diagnosed with metastatic small-cell lung cancer. Here, three survivors share their stories.

The prognosis for non-small cell lung cancer (NSCLC) can depend on several factors, including the stage of your disease. Survival rates also vary.

The Phase II trial will compare progression-free survival in lung cancer patients treated according to their molecular subtypes.

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.